CYC.ASX: Immediate 11-Site Technegas Rollout at University Hospitals

Immediate 11-Site Technegas Rollout at University Hospitals

Stock	Cyclopharm Ltd (CYC.ASX)
Release Time	15 Jul 2026, 8:29 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Cyclopharm Announces Immediate Technegas Rollout at University Hospitals

Key Points

Cyclopharm secures agreement with University Hospitals for Technegas installations
Agreement covers immediate deployment across 11 clinical locations
Strengthens Cyclopharm's presence in the US healthcare market
Reflects confidence in Technegas's clinical utility and potential for growth

Full Summary

Cyclopharm Limited (ASX: CYC) has entered into a significant agreement with University Hospitals (UH), Cleveland, Ohio, for the immediate installation of Technegas across 11 clinical locations. This agreement marks a major milestone in Cyclopharm's US expansion strategy, with all installations set to be completed within weeks. UH's decision to prepare all sites ahead of signing underscores its commitment to the rollout. The agreement not only deepens Cyclopharm's footprint in northern Ohio but also positions Technegas as a key tool in functional ventilation imaging, with potential applications in various respiratory conditions and interventional lung procedures. Cyclopharm's Managing Director and CEO, James McBrayer, highlighted the significance of this agreement, emphasizing the immediate, system-wide deployment as a testament to Technegas's recognized clinical value.